World's Best Scientists 2026 revealed!
Award Badge
Psychology
UK
2026

D-Index & Metrics

Medicine

D-Index
109
Citations
61771
World Ranking
5673
National Ranking
558

Psychology

D-Index
108
Citations
59978
World Ranking
418
National Ranking
63

Alistair Burns publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Alistair Burns sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 544 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Alistair Burns D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Alistair Burns sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 108 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Psychology in United Kingdom Leader Award

Overview

Alistair Burns is affiliated with the University of Manchester in the United Kingdom and has published extensively in the field of medicine, with a focus on psychiatry, clinical psychology, geriatrics, and neurology. Their research primarily addresses dementia, cognitive impairment, and geriatric care, with significant contributions to the understanding of COVID-19's impact on mental health and long-term cognitive disorders.

Their body of work includes a number of frequently cited papers, such as:

  • Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020, The Lancet)
  • Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024, The Lancet)
  • Mild Cognitive Impairment: the Manchester consensus (2020, Age and Ageing)
  • Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management (2020, Journal of Neurology Neurosurgery & Psychiatry)
  • Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gaps (2021, International Journal of Geriatric Psychiatry)

Their main research topics encompass:

  • Dementia and Cognitive Impairment Research
  • Geriatric Care and Nursing Homes
  • Intensive Care Unit Cognitive Disorders
  • Frailty in Older Adults
  • COVID-19 and Mental Health
  • Healthcare Decision-Making and Restraints
  • Long-Term Effects of COVID-19

Frequent collaborative work includes partnerships with a number of noted researchers, specifically:

  • Sube Banerjee (24 joint publications)
  • Iracema Leroi (20 joint publications)
  • Robert Howard (16 joint publications)
  • Vanessa Lawrence (14 joint publications)
  • Gill Livingston (11 joint publications)

Their publications commonly appear in the following venues:

  • International Journal of Geriatric Psychiatry (19 publications)
  • BMJ Open (4 publications)
  • Alzheimer's & Dementia (4 publications)
  • The Lancet (3 publications)
  • BJPsych Advances (3 publications)

Alistair Burns' research spans several subfields, including psychiatry and mental health, clinical psychology, general health professions, geriatrics and gerontology, and neurology, reflecting an interdisciplinary approach to improving understanding and care in aging and dementia-related conditions.

Best Publications

  • Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

    Gill Livingston;Gill Livingston;Jonathan Huntley;Andrew Sommerlad;Andrew Sommerlad;David Ames

  • Dementia prevention, intervention, and care

    Gill Livingston;Gill Livingston;Andrew Sommerlad;Vasiliki Orgeta;Sergi G Costafreda;Sergi G Costafreda

  • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop

    I. G. Mckeith;D. Galasko;K. Kosaka;E. K. Perry

  • Vascular Cognitive Impairment

    John T O'Brien;Timo Erkinjuntti;Barry Reisberg;Gustavo Roman

  • Clinical Diagnosis of Alzheimer's Disease

    Alistair Burns

  • Putting brain training to the test

    Adrian M. Owen;Adam Hampshire;Jessica A. Grahn;Robert Stenton

  • Health of the Nation Outcome Scales (HoNOS). Research and development.

    J. K. Wing;A. S. Beevor;R. H. Curtis;S. B. G. Park

  • Donepezil and memantine for moderate-to-severe Alzheimer's disease.

    Robert Howard;Rupert McShane;James Lindesay;Craig Ritchie

  • The effects of donepezil in Alzheimer's disease - results from a multinational trial.

    A. Burns;M. Rossor;J. Hecker;S. Gauthier

  • Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial

    Sube Banerjee;Jennifer Hellier;Michael Dewey;Renee Romeo

  • Alzheimer’s disease

    Unknown

  • Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations

    Lucy Webster;Derek Groskreutz;Anna Grinbergs-Saull Grinbergs-Saull;Rob Howard

  • Determinants of carer stress in Alzheimer's disease

    C. Donaldson;N. Tarrier;A. Burns

  • Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content.

    Alistair Burns;Robin Jacoby;Raymond Levy

  • Efficacy and Tolerability of Donepezil in Vascular Dementia Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial

    Sandra Black;Gustavo C. Román;David S. Geldmacher;Stephen Salloway

  • Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.

    Howard H. Feldman;Steven Ferris;Bengt Winblad;Nikolaos Sfikas

  • The impact of the symptoms of dementia on caregivers.

    Catherine Donaldson;Nicholas Tarrier;Alistair Burns

  • Donepezil for the treatment of agitation in Alzheimer's disease

    Robert J. Howard;Edmund Juszczak;Clive G. Ballard;Peter Bentham

  • Effectiveness of cognitive—behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer's disease

    Alison Marriott;Catherine Donaldson;Nicholas Tarrier;Alistair Burns

  • Psychiatric phenomena in Alzheimer's disease. II: Disorders of perception.

    Alistair Burns;Robin Jacoby;Raymond Levy

  • Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood.

    Alistair Burns;Robin Jacoby;Raymond Levy

  • The Lewy-body variant of Alzheimer's disease : clinical and pathological findings

    Hans Förstl;Alistair Burns;Phil Luthert;Nigel Cairns

  • Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356

    Alistair Burns;Bernard Tomlinson;D.M.A. Mann

Frequent Co-Authors

David Challis
David Challis University of Nottingham
Robert Baldwin
Robert Baldwin London School of Economics and Political Science
Clive Ballard
Clive Ballard University of Exeter
Robert Howard
Robert Howard University College London
John T. O'Brien
John T. O'Brien University of Cambridge
Martin Knapp
Martin Knapp London School of Economics and Political Science
Hans Förstl
Hans Förstl Technical University of Munich
Sube Banerjee
Sube Banerjee Plymouth University
Alan Jackson
Alan Jackson Arizona State University
Clive Holmes
Clive Holmes University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Psychology studies open the door to a variety of online degrees and professional pathways. One popular career is becoming a speech-language pathologist, which requires both specialized education and meeting state-specific licensing requirements.

For those interested in becoming a speech therapist in Maryland, it’s important to understand the necessary graduate training and certifications involved. Each state has its own set of standards. For example, Massachusetts speech pathologist certification requirements are distinct, focusing on both clinical experience and examinations.

States like Michigan and Minnesota also set their own processes. If you are interested in becoming a speech therapist in Michigan, you’ll need to meet the state’s specific education, clinical practicum, and assessment standards. Likewise, slp requirements in Minnesota include a master’s degree and passing relevant national exams.

By exploring these pathways, students can find a career that blends psychological knowledge with practical impact, addressing communication challenges and making a real difference in people’s lives.

Best Scientists Citing Alistair Burns

Trending Scientists

Recently Published Articles